170 related articles for article (PubMed ID: 23824464)
1. A prospective analysis of ¹⁸F-FDG PET/CT in patients with uveal melanoma: comparison between metabolic rate of glucose (MRglu) and standardized uptake value (SUV) and correlations with histopathological features.
Calcagni ML; Mattoli MV; Blasi MA; Petrone G; Sammarco MG; Indovina L; Mulè A; Rufini V; Giordano A
Eur J Nucl Med Mol Imaging; 2013 Oct; 40(11):1682-91. PubMed ID: 23824464
[TBL] [Abstract][Full Text] [Related]
2. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in patients with liver metastases from uveal melanoma: results from a pilot study.
Orcurto V; Denys A; Voelter V; Schalenbourg A; Schnyder P; Zografos L; Leyvraz S; Delaloye AB; Prior JO
Melanoma Res; 2012 Feb; 22(1):63-9. PubMed ID: 22027909
[TBL] [Abstract][Full Text] [Related]
3. Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.
Visser EP; Philippens ME; Kienhorst L; Kaanders JH; Corstens FH; de Geus-Oei LF; Oyen WJ
J Nucl Med; 2008 Jun; 49(6):892-8. PubMed ID: 18483085
[TBL] [Abstract][Full Text] [Related]
4. [(18)F]Fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) physiologic imaging of choroidal melanoma: before and after ophthalmic plaque radiation therapy.
Finger PT; Chin KJ
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):137-42. PubMed ID: 20395070
[TBL] [Abstract][Full Text] [Related]
5. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
[TBL] [Abstract][Full Text] [Related]
6. Whole-Body [
Berzaczy D; Fueger B; Hoeller C; Haug AR; Staudenherz A; Berzaczy G; Weber M; Mayerhoefer ME
Mol Imaging Biol; 2020 Jun; 22(3):739-744. PubMed ID: 31363965
[TBL] [Abstract][Full Text] [Related]
7. Limited value of 18F-FDG PET/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous melanoma.
Strobel K; Bode B; Dummer R; Veit-Haibach P; Fischer DR; Imhof L; Goldinger S; Steinert HC; von Schulthess GK
Eur J Nucl Med Mol Imaging; 2009 Nov; 36(11):1774-82. PubMed ID: 19495748
[TBL] [Abstract][Full Text] [Related]
8. Glucose metabolism and pathological findings in uveal melanoma: preliminary results.
Modorati G; Lucignani G; Landoni C; Freschi M; Trabucchi G; Fazio F; Brancato R
Nucl Med Commun; 1996 Dec; 17(12):1052-6. PubMed ID: 9004302
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
10. Low efficacy of 18F-FDG PET for detection of uveal malignant melanoma compared with 123I-IMP SPECT.
Kato K; Kubota T; Ikeda M; Tadokoro M; Abe S; Nakano S; Nishino M; Kobayashi H; Ishigaki T
J Nucl Med; 2006 Mar; 47(3):404-9. PubMed ID: 16513608
[TBL] [Abstract][Full Text] [Related]
11. Metabolic activity of primary uveal melanoma on PET/CT scan and its relationship with monosomy 3 and other prognostic factors.
Papastefanou VP; Islam S; Szyszko T; Grantham M; Sagoo MS; Cohen VM
Br J Ophthalmol; 2014 Dec; 98(12):1659-65. PubMed ID: 25084771
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of the standardized uptake value for (18)F-fluorodeoxyglucose in patients with stage IIIB melanoma.
Bastiaannet E; Hoekstra OS; de Jong JR; Brouwers AH; Suurmeijer AJ; Hoekstra HJ
Eur J Nucl Med Mol Imaging; 2012 Oct; 39(10):1592-8. PubMed ID: 22801730
[TBL] [Abstract][Full Text] [Related]
13. Whole-body F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography imaging in the follow-up of metastatic uveal melanoma.
Klingenstein A; Haug AR; Nentwich MM; Tiling R; Schaller UC
Melanoma Res; 2010 Dec; 20(6):511-6. PubMed ID: 20890225
[TBL] [Abstract][Full Text] [Related]
14. High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases.
Strobel K; Dummer R; Husarik DB; Pérez Lago M; Hany TF; Steinert HC
Radiology; 2007 Aug; 244(2):566-74. PubMed ID: 17641374
[TBL] [Abstract][Full Text] [Related]
15. Multi-modality imaging of uveal melanomas using combined PET/CT, high-resolution PET and MR imaging.
Beyer T; Pietrzyk U; Knoess C; Vollmar S; Wienhard K; Kracht L; Bockisch A; Maderwald S; Kühl H; Fitzek M
Nuklearmedizin; 2008; 47(2):73-9. PubMed ID: 18392316
[TBL] [Abstract][Full Text] [Related]
16. Effects of administration route, dietary condition, and blood glucose level on kinetics and uptake of 18F-FDG in mice.
Wong KP; Sha W; Zhang X; Huang SC
J Nucl Med; 2011 May; 52(5):800-7. PubMed ID: 21498533
[TBL] [Abstract][Full Text] [Related]
17. Reproducibility of functional volume and activity concentration in 18F-FDG PET/CT of liver metastases in colorectal cancer.
Heijmen L; de Geus-Oei LF; de Wilt JH; Visvikis D; Hatt M; Visser EP; Bussink J; Punt CJ; Oyen WJ; van Laarhoven HW
Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1858-67. PubMed ID: 22945372
[TBL] [Abstract][Full Text] [Related]
18. Determination of regional lymph node status using (18)F-FDG PET/CT parameters in oesophageal cancer patients: comparison of SUV, volumetric parameters and intratumoral heterogeneity.
Kim SJ; Pak K; Chang S
Br J Radiol; 2016; 89(1058):20150673. PubMed ID: 26607643
[TBL] [Abstract][Full Text] [Related]
19. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
[TBL] [Abstract][Full Text] [Related]
20. [The application of (18)F fluorodeoxyglucose-positron emission tomography/computed tomography in the diagnosis and treatment of dermatomyositis].
Pei L; Guan ZW; Ji XJ; Wen QF; Sun F; Zhao Z; Jin JY; Zhu J; Zhang JL; Huang F
Zhonghua Nei Ke Za Zhi; 2016 Jul; 55(7):525-30. PubMed ID: 27373287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
